Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Thomas A. Giever DO
Assistant Professor
Department of Medicine
Division of Hematology and Oncology - Medicine

OFFICE ADDRESS:
Froedtert Hospital
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
08/1999 - 05/2003 BS, University of Portland, Portland, OR
08/2004 - 05/2008 DO, Kansas City University of Medicine, Kansas City, MO
01/2005 - 05/2008 MBA, Rockhurst University, Kansas City, MO
08/2018 - 05/2019 Courses towards graduate certificate in clinical bioethics, Medical College of Wisconsin, Milwaukee, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/2008 - 06/2009 Intern, Internal Medicine, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI
07/2009 - 06/2011 Resident, Internal Medicine, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI
07/2012 - 06/2014 Fellow, Medicine, Hematology and Oncology, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI
07/2014 - 06/2015 Chief fellow, Medicine, Hematology and Oncology, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI

FACULTY APPOINTMENTS:
07/2011 - 06/2012 Assistant Professor of Medicine, Medicine, General Internal Medicine, Medical College of Wisconsin, Milwaukee, WI
04/2017 - 12/2017 Adjunct Clinical Associate Professor, Clinical Medicine, Pacific Northwest University, Yakima, WA
01/2018 - Present Assistant Professor of Medicine, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
07/2011 - 06/2012 General Internal Medicine Hospitalist, Clement J Zablocki VA Medical Center, Milwaukee, WI
08/2015 - 12/2017 Hematology and Oncology, North Star Lodge Cancer Center, Yakima, WA
01/2018 - Present Medical Director for Hematology and Oncology, Froedtert & Medical College of Wisconsin Drexel Town Square Health Center Cancer Center, Oak Creek, WI
01/2018 - Present Genitourinary Oncology, Froedtert & Medical College of Wisconsin Clinical Cancer Center, Milwaukee, WI
01/2018 - Present Medical Director, Froedtert & Medical College of Wisconsin Drexel Town Square Health Center Cancer Center, Oak Creek, WI
01/2018 - Present Hematology and Oncology, Froedtert & Medical College of Wisconsin Drexel Town Square Health Center Cancer Center, Oak Creek, WI

HOSPITAL STAFF PRIVILEGES:
07/2011 - 06/2012 Clement J Zablocki VA Medical Center, Milwaukee, WI
07/2015 - 12/2017 Astria Regional Medical Center (formerly Yakima Regional Medical Center), Yakima, WA
07/2015 - 12/2017 MultiCare Yakima Memorial Hospital (formerly Yakima Valley Memorial, Virginia Mason Memorial Hospital, and Yakima Valley Memorial Hospital), Yakima, WA
02/2017 - 12/2017 Kittitas Valley Hospital, Ellensburg, WA
01/2018 - Present Froedtert Menomonee Falls Hospital (formerly Community Memorial Hospital), Menomonee Falls, WI
01/2018 - Present Froedtert West Bend Hospital (formerly St Joseph Hospital of West Bend), West Bend, WI
01/2018 - Present Froedtert Memorial Lutheran Hospital, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Internal Medicine
08/2011
08/2031
Medical Oncology
08/2015
08/2025
   
Certificates
Issued By Issue DateExpiration
ACLS
AHA
05/2006
05/2016
BLS
AHA
05/2006
05/2016
DEA
03/2011
09/2025
CITI
01/2018
12/2026
    

Licensure
Number Issue DateExpiration
WI license
53988-21
02/2010
10/2025
Washington License
OP60533393
02/2015
03/2024
    

AWARDS AND HONORS:
07/2014 - 06/2015 Mazie Froedtert Willms and Sue Froedtert Cancer Fellowship, Froedtert Hospital Foundation
08/2014 - Present Outstanding Fellow Award, Wisconsin Association of Hematology and Oncology

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
08/2004 - 05/2008 Missouri State Medical Society
08/2004 - 12/2014 American Osteopathic Association
08/2004 - 12/2017 American Medical Association
07/2008 - 06/2015 Wisconsin Medical Society
07/2009 - 06/2017 American College of Physicians
07/2012 - 12/2019 American Society of Hematology
07/2012 - Present American Society of Clinical Oncology
07/2014 - 06/2015 American Association for Cancer Research
02/2016 - 12/2016 Washington State Medical Society
01/2018 - Present Wisconsin Association of Hematology and Oncology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
08/2015 - 12/2017 Member, Clinical Trials Steering Committee, North Star Lodge Cancer Center
01/2017 - 12/2017 Member, Northwest NCI Community Oncology Research Program (SWOG), North Star Lodge Cancer Center
01/2018 - 12/2020 Board of Trustees member-at-large, Wisconsin Association of Hematology and Oncology
01/2021 - 12/2022 Board of Trustees treasurer, Wisconsin Association of Hematology and Oncology
03/2021 - Present Member, Wisconsin Association of Hematology and Oncology State Society Policy Engagement Subcommittee
01/2023 - Present Board of Trustees president, Wisconsin Association of Hematology and Oncology

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
01/2016 - 12/2017 North Star Lodge Cancer Center representative, Advanced Therapeutics Research Program, US Oncology
01/2016 - 12/2017 North Star Lodge Cancer Center representative, Gastrointestinal Research Program, US Oncology

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
National
Medical oncology and colon cancer, Yakima Valley Memorial Hospital 2016 Endoscopy Course, Yakima Valley Memorial Hospital, Yakima, WA, 03/12/2016
Neuroendocrine tumors, Yakima Valley Memorial Hospital Multidisciplinary Journal Club, AntoLin Cellars, Yakima, WA, 03/22/2017
 
Local
Utility of invasive staging procedures in patients with localized esophageal cancer, Medical College of Wisconsin Hematology and Oncology Research Meeting, Froedtert Hospital, 04/16/2015
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
Local
Giever TA, A challenging case of two distinct cancer, what to treat when?, Oral presentation at the Wisconsin Association of Hematology and Oncology 2014 Annual Membership Conference, isconsin Association of Hematology and Oncology, Milwaukee, WI, 09/2014
 

COMMITTEE SERVICE:
Medical College of Wisconsin
05/2018 - Present Member, Institutional Review Board Committee #4, Medical College of Wisconsin
07/2018 - Present Member, Genitourinary Disease Oriented Team, F&MCW Clinical Cancer Center
07/2018 - Present Member, Community Practice Disease Oriented Team, F&MCW Clinical Cancer Center
07/2020 - Present Liaison, F&MCW Community Practice Disease Oriented Team, National Cancer Institute National Clinical Trial Network Lead Academic Participating Sites
07/2021 - Present Member, Quality & Value committee, Genitourinary Disease Oriented Team, F&MCW Clinical Cancer Center
07/2021 - Present Member, Early Phase Disease Oriented Team, F&MCW Clinical Cancer Center
09/2021 - Present Member, Breast Disease Oriented Team, F&MCW Clinical Cancer Center
 
Hospital
01/2018 - Present Affiliate site PI, F&MCW Drexel Town Square Health Center Cancer Center, ECOG-ACRIN, F&MCW Clinical Cancer Center
04/2019 - Present Affiliate site representative, F&MCW Drexel Town Square Health Center Cancer Center, Academic and Community Research United, F&MCW Clinical Cancer Center
07/2019 - Present Founding co-chair, Innovative Therapies Subcommittee, F&MCW System Pharmacy and Therapeutics Committee, Froedtert Health
06/2022 - Present Member, Oncology Subcommittee, F&MCW System Pharmacy and Therapeutics Committee, Froedtert Health
 

MCW TEACHING ACTIVITIES:
Resident and Fellow Education
02/2021 Chad Glisch, rotating fellow in GU malignancies clinic
07/2022 Matthew Weber, rotating fellow in GU malignancies clinic
11/2022 Michael Pierro, rotating fellow in GU malignancies clinic
02/2023 Gulrayz Ahmed, rotating fellow in GU malignancies clinic
03/2023 - 06/2023 Kathleen Monahan, continuity fellow in GU malignancies clinic
05/11/2023 IM Residency Core Skills 301-Oncology
08/2023 Michael Pierro, rotating fellow in GU malignancies clinic
10/2023 Annie Kim, rotating fellow in GU malignancies clinic
11/2023 Amer Al Homssi, rotating fellow in GU malignancies clinic
12/2023 Adam Kidwell, rotating fellow in GU malignancies clinic
12/2023 Grace Ying, rotating fellow in GU malignancies clinic
 

EXTRAMURAL TEACHING:
Resident and Fellow Education
01/02/2019 F&MCW Radiation Oncology Residency grand rounds, Updates in systemic therapy for prostate cancer
03/04/2024 F&MCW Hematology and Oncology Fellowship education conference, Early-stage prostate cancer
 
Continuing Medical Education
09/06/2016 North Star Lodge Cancer Center, Yakima, WA, Medical oncology and colon cancer, North Star Lodge Cancer Center CME
03/02/2017 North Star Lodge Cancer Center, Yakima, WA, Introduction to medical imaging, North Star Lodge Cancer Center Nursing Educational Series
03/03/2017 North Star Lodge Cancer Center, Yakima, WA, Introduction to medical imaging, North Star Lodge Cancer Center Nursing Educational Series
 
Community/Lay Public
05/2016 Skin cancer, Newstalk 1280AM KIT, Yakima, WA
10/2018 WTMJ Everyday Health, Milwaukee, WI, Breast cancer
07/04/2019 - 07/05/2019 Froedtert Today, Extending Academic Medicine’s Reach
09/10/2019 Drexel Town Square Community Advisory Council, Oak Creek, WI, Drexel Town Square Health Center Cancer Center updates
01/2020 WTMJ Everyday Health, Milwaukee, WI, Clinical trials
12/08/2020 &MCW Drexel Town Square Health Center Community, Prostate cancer, Education Class, Online
03/16/2022 - 03/17/2022 Froedtert Today, No Ordinary Joe
Virginia Mason Memorial, North Star Lodge Cancer Center, Oncology Issues. 2017; 33(3): 16-17.
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Clinical Staff
01/2018 - 03/2020 Mary Elizabeth Holden, PA-C, WI 3001-23, Medical College of Wisconsin
08/2020 - 02/2022 Kristin Zutavern, PA-C, WI 5018-23, Medical College of Wisconsin
02/2021 - 06/2021 Molly Kortsch, APNP, WI 8042-33, Medical College of Wisconsin
03/2021 - 05/2021 Jessica Noll, APNP, WI 4641-33, Medical College of Wisconsin
10/2021 - 04/2023 Sarah Ramirez, PA-C, WI 1942-23, Medical College of Wisconsin
10/2022 - Present Kelsey Knapp, APNP, WI 11472-33, Medical College of Wisconsin
11/2023 - Present Abbigail Brauch, PA-C, WI 4159-23, Medical College of Wisconsin
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Faculty
01/2013 - 12/2013 Member, Geriatrics Education Team for Hematology and Oncology, Medical College of Wisconsin
01/2020 WI representative, Leaders in Oncology Program, Oncology State Societies at Association of Community Cancer Centers, Dana Point, CA
01/2022 WI representative, Leaders in Oncology Program, Oncology State Societies at Association of Community Cancer Centers, Miami, FL
01/2023 WI representative, Leaders in Oncology Program, Oncology State Societies at Association of Community Cancer Centers, Scottsdale, AZ
01/2024 WI representative, Leaders in Oncology Program, Oncology State Societies at Association of Community Cancer Centers, Rio Grande, Puerto Rico
 
 
Clinical Programs
07/2014 - 06/2015 Member, Inpatient Leadership Workgroup, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin
10/2015 - 01/2016 Member, Virginia Mason GI Cancer Integration Team, North Star Lodge Cancer Center
01/2016 - 12/2016 Member, CMS Oncology Care Model Navigation and Care Coordination Workgroup, North Star Lodge Cancer Center
01/2017 - 12/2017 Member, Cerner Oncology EMR Development Planning Workgroup, North Star Lodge Cancer Center
 
Community Programs
09/16/2020 09/16/2020, WI representative, American Society of Clinical Oncology Advocacy Summit, virtual
04/14/2021 WI representative, American Society of Clinical Oncology Advocacy Summit, virtual
01/20/2022 Co-author, MCW letter of support for Senate Bill 753, to WI State Senate Committee on Insurance, Licensing and Forestry
04/07/2022 WI representative, American Society of Clinical Oncology Advocacy Summit, virtual
05/24/2023 Co-author, Wisconsin Association of Hematology and Oncology State Society letter of support for cancer drug shortages, to Rep Tom Tiffany
12/06/2023 Co-author, Wisconsin Association of Hematology and Oncology State Society and Association for Clinical Oncology letter of support for SB 811, to Sen Mary Felzkowski
12/06/2023 Co-author, Wisconsin Association of Hematology and Oncology State Society and Association for Clinical Oncology letter of support for SB 737, to Sen Mary Felzkowski
01/24/2024 Co-author, Wisconsin Association of Hematology and Oncology State Society and Association for Clinical Oncology letter of support for AB 860, to Rep Barbara Dittrich
01/24/2024 Co-author, Wisconsin Association of Hematology and Oncology State Society and Association for Clinical Oncology letter of support for AB 773, to Rep Clint Moses
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Giever T, Gottlieb K, Merg A. Endoscopic repair of a complete post-radiation esophageal obstruction. J Gastrointestin Liver Dis. 2008; 17(3): 335-8.
2. Stilgenbauer S, Morschhauser F, Wendtner CM, Cartron G, Hallek M, Eichhorst B, Kozloff M, Giever T, Lozanski G, Jiang Y, Huang H, Pignataro DS, Schary W, Humphrey K, Mobasher M, Salles G. Venetoclax and bendamustine plus rituximab or Obinutuzumab in CLL: final results of a phase Ib study (GO28440). Haematologica. 2021; 106(11): 2834-2844.
3. Berlin KEK, Szabo A, Ramalingam S, Bhasin B, Bhosekar CS, Nelson A, Giever T, Pawlenty A, Kilari D, Wong SJ. Mannitol administration and the risk of cisplatin-induced nephrotoxicity. Submitted to Journal of Hematology Oncology Pharmacy.
4. Kamaraju S, Folwer AM, Tarima S, Burkard M, Chaudhary L, Giever T, Cheng YC, Parkes A, Lange C, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns J, Rui H, Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K. A phase II trial of onapristone in combination with fulvestrant for patients with ER-positive, and HER2-negative metastatic breast cancer after progression on endocrine therapy and CDK 4/6 inhibitors.
 
Books, Chapters, and Reviews
1. Kamaraju S, Folwer AM, Tarima S, Burkard M, Chaudhary L, Giever T, Cheng YC, Parkes A, Lange C, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns J, Rui H, Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K. A phase II trial of onapristone in combination with fulvestrant for patients with ER-positive, and HER2-negative metastatic breast cancer after progression on endocrine therapy and CDK 4/6 inhibitors.
 
Non-Refereed Journal Publications/Original Papers
1. Denson K, Giever T, Dreger N, Foy P, Manzi G, Rehm, J. Geriatric oncology OSCE: using geriatric assessment tools to guide patient treatment decisions. AAMC MedEdPORTAL; published online, 2014. http://www.mededportal.org/publication/9860.
2. Manzi G, Giever T, Dreger N, Denson K, Foy P. Geriatric Fast Facts #36: Should your patient have that oncology intervention? MCW Geriatric Fast Facts; published online, 2013. http://www.mcw.edu/Geriatric-Fast-Facts/036.htm
3. Giever T, Denson K, Dreger N, Foy P, Manzi G. Geriatric Fast Facts #37: Chemotherapy toxicity in the geriatric patient. MCW Geriatric Fast Facts; published online, 2013. http://www.mcw.edu/Geriatric-Fast-Facts/index37.htm.
4. Dreger N, Giever T, Foy P, Manzi G, Denson K. Geriatric Fast Facts #39: Etiologies of anemia in elderly patients. MCW Geriatric Fast Facts; published online, 2013. http://www.mcw.edu/Geriatric-Fast-Facts/039-Geriatric-Fast-Fact.htm.
 
Abstracts
1. Giever TA, Adwan KM, Cheng YC, Atallah EL. Comparison of venous thromboemboli (VTE) incidence in cancer patients on statin therapy versus those not on statin therapy. J Clin Oncol. 2010; 28(15s): abstr 9033. a. Poster presentation at the 2010 ASCO Annual Meeting. Chicago, IL. b. Poster presentation at the 2010 MCW Research Day. Milwaukee, WI.
2. Giever TA, Hari PN. Refractory syncopal episodes with recurrent pericardial and pleural effusions. a. Poster presentation at the 2010 SGIM Midwest Regional Meeting. Chicago, IL.
3. Giever TA, Pfeifer KJ, Hari PN. Rare etiology of renal failure in a 35-year-old female. a. Poster presentation at the 2011 SGIM Annual Meeting. Phoenix, AZ.
4. Giever TA, Pfeifer KJ. Unexpected etiology of hip pain in a young woman. a. Poster presentation at the 2011 SGIM Annual Meeting. Phoenix, AZ.
5. Giever TA, Richter EL, Broge KM, Foy PC, Blust LS, Palmer JM, Fenske TS, Rilling WS, Hari PN, Atallah EL. Incidence of venous thromboembolism in patients with hematological malignancies related to upper extremity peripherally inserted central venous catheters. J Clin Oncol. 2013; 31(15s): abstr 6586. a. Poster presentation at the 2013 ASCO Annual Meeting. Chicago, IL. b. Poster presentation at the 2013 MCW Research Day. Milwaukee, WI.
6. Giever TA, Foy PC, Manzi G, Denson K, Dreger N, Rehm J. Development of a geriatrics specific curriculum within a hematology-oncology fellowship program to improve training in the treatment of elderly patients with cancer. J NCCN. 2014; 12(4): 456-457. a. Poster presentation at the 2014 NCCN Annual Meeting. Hollywood, FL.
7. Giever TA, Ritch PS, Thomas JP, Wiebe LA, Haasler GB, Gasparri MG, Johnstone DW, Johnstone CA, Gore EM, George B. A combination of cisplatin, irinotecan, and paclitaxel (CIP) as frontline treatment of patients with metastatic eosphageal cancer (mEC). Cancer Res. 2014; 74(19s): abstr 813. a. Poster presentation at the 2014 AACR Annual Meeting. San Diego, CA. b. Poster presentation at the 2014 24th Annual Mayo Clinic Hematology/Oncology Review and 15th Annual Fellows Presentations. Amelia Island, FL.
8. Baumann Kreuziger L, Richter EL, Gomez Timana L, Giever TA, Atallah EL. Duration of anticoagulation treatment for catheter-related thrombosis in hematologic malignancy. J Thromb Haemost. 2014; 12(s1); abstr HM10. a. Poster presentation at the 2014 International Society of Thrombosis and Haemostasis Scientific and Standardization Committee Meeting. Milwaukee, WI. b. Poster presentation at the 2014 MCW Research Day. Milwaukee, WI.
9. Giever TA, Rande A, Thomas JP, Ritch PS, Haasler GB, Gasparri MG, Johnstone DW, Gore EM, Johnstone CA, Dua K, Khan A, Oh Y, George B. Utility of invasive staging procedures in patients (pts) with localized esophageal cancer (EC). J Clin Oncol. 2015; 33(3s): abstr 54. a. Poster presentation at the 2015 ASCO Gastrointestinal Cancers Symposium. San Francisco, CA.
10. Giever TA, Giever ER, Foy PC, Baumann Kreuziger L, Michaelis LC, Carlson KSB, Fenske TS, Hamadani M, Rilling WS, Hari PN, Atallah EL. Incidence of catheter-related venous thromboembolism in peripherally inserted central venous catheters vs tunneled chest central venous catheters in patients with hematologic malignancies. J Clin Oncol. 2015; 33(15s): abstr e20684.
11. Stilgenbauer S, Morschhauser F, Wendtner CM, Cartron G, Hallek M, Eichhorst B, Kozloff M, Giever T, Lozanski G, Punnoose E, Wang J, Hilger J, Mobasher M, Salles G. Phase Ib study (GO28440) of venetoclax with bendamustine/rituximab or bendamustine/obinutuzumab in patients with relapsed/refractory or previously untreated chronic lymphocytic leukemia. Blood. 2016; 128: abstr 4393.
12. Sharman JP, Kolibaba K, Shustov A, Giever T, Klein L, Nay D, Rado T, Saleh A, Forero A, Zhang D, Shi W, Assouline S. Phase 2 trial evaluating efficacy and safety of entospletinib (GS-9973) in subjects with mantle cell lymphoma. Blood. 2016; 128: abstr 2963. a. Poster presentation at the 2016 ASH Annual Meeting. San Diego, CA.
13. Sharman JP, Kolibaba K, Azar J, Balaraman R, Lyons R, Smith M, Abella-Dominicis E, Ye W, Shi W, Giever T, Forero-Torres A. Evaluating the efficacy, safety, and dose dependent activities of entosplentinib in patients with chronic lymphocytic leukemia. Blood. 2017; 130: abstr 832. a. Oral presentation at the 2017 ASH Annual Meeting. Atlanta, GA.
14. Stilgenbauer S, Morschhauser F, Wendtner CM, Cartron G, Hallek M, Eichhorst B, Kozloff M, Giever T, Lozanski G, Jiang Y, Soriano Pignataro D, Schary W, Humphrey K, Mobasher M, Salles G. Safety and efficacy of venetoclax (VEN) in combination with bendamustine (B) plus rituximab (R) or Obinutuzumab (G) in patients (pts) with previously untreated chronic lymphocytic leukemia (CLL): results from a phase 1b study (GO28440). Blood. 2018; 132: abstr 1859. a. Poster presentation at the 2018 ASH Annual Meeting. San Diego, CA.
15. Nelson A, Cronk R, Szabo A, Lemke E, Giever T, Burfeind J, Kilari D, Riese M, Bylow K, Diamantopoulos N, Khaki A, Nezami B, MacLennan G, Draves M, Goolamier G, Rosey S, Calaway A, Grivas P, Ponsky L, Hoimes C. Emerging clinical phenotype of bone metastatic urothelial cancer (mUC): association of early osseous metastases (EOM) and outcomes. J Clin Oncol. 2020; 38(15s): abstr e17007.
16. Kilari D, Szabo A, Hall W, Nelson A, Giever T, Burfeind J, Tolat P, Johnson S, Bylow K, Iczkowski KA, Sun Y, Rui H, Thomas JP, Nevalainen MT. A single-arm, open-label, phase 2 study evaluating pacritinib for patients with biochemical recurrence after definitive treatment for prostate cancer: BLAST study. J Clin Oncol. 2022; 40(6s): abstr TPS220. a. Poster presentation at the 2022 ASCO GU Symposium. San Francisco, CA.
17. Kamaraju S, Fowler A, Chaudhary L, Burkard M, Giever T, Cheng YC, Parkes A, Jorns J, Retseck J, Sriram D, Lange C, Wisinski K. The SMILE Study: a phase II trial of onapristone in combination with fulvestrant for patients with ER-positive and HER2-negative metastatic breast cancer after progression on endocrine therapy and CDK 4/6 inhibitors. Cancer Res. 2023; 83(5s): P4-01-19. a. Poster presentation at the 2022 San Antonio Breast Cancer Symposium. San Antonio, TX.
18. Kamaraju S, Fowler A, Chaudhary L, Burkard M, Giever T, Cheng YC, Parkes A, Jorns J, Retseck J, Sriram D, Lange C, Pipp M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Zurbriggen L, Rui H, Wisinski K. A phase 2 trial of onapristone in combination with fulvestrant for patients with ER-positive and HER2-negative metastatic breast cancer after progression on endocrine therapy and CDK4/6 inhibitors. a. Submitted to the 2023 ASCO Annual Meeting. Chicago, IL.
19. Depke M, Summey R, Hopp E. Cardiovascular disease contributes to racial disparities in endometrial cancer outcomes. J Clin Oncol. 2023; 41(16s): abstr 5602. a. ASCO member sponsor. b. Poster presentation at the 2023 ASCO Annual Meeting. Chicago, IL.
20. Kilari D, Szabo A, Hall W, Burfeind J, Giever T, Hoyer D, Kanellopoulos K, Sun Y, Iczkowski K, Nelson A, Rui H, Bylow K, Buckley S, Nevalainen M. A single-arm, open-label, phase 2 study evaluating pacritinib (PAC) for patients (pts) with biochemical relapse (BCR) after definitive treatment for prostate cancer (PC): BLAST study interim analysis. a. Submitted to the 2023 ESMO Congress. Madrid, Spain.
21. Kamaraju S, Fowler A, Chaudhary L, Burkard M, Giever T, Cheng YC, Parks A, Jorns J, Retseck J, Sriram D, Lange C, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Raiguru S, Zurbiggen L, Rui H, Wisinski K. The SMILE study: A phase II trial of onapristone in combination with fulvestrant for patients with ER-positive and HER2-negative metastatic breast cancer after progression on endocrine therapy and CDK 4/6 inhibitors. a. Submitted to the 2023 San Antonio Breast Cancer Symposium. San Antonio, TX.
22. Kilari D, Szabo A, Burfeind J, Giever T, Nelson A, Bylow K, Maqbool M, Surapally S, Nevalainen M. A single-arm, open-label, phase 2 study evaluating pacritinib for patients with biochemical relapse after definitive treatment for prostate cancer: BLAST study interim analysis. a. Submitted to the 2024 ASCO GU Symposium. San Francisco, CA.
 
Database, Video, or Other Research/Clinical Contributions
1. Cook C, Richmond M, Coleman A, Rakowski C, Titzler S, Bleich M. Numerically simulating the hydrodynamic and water quality environment for migrating salmon in the lower Snake. Prepared for the US Department of Energy. 2003.
2. Deng Z, Richmond M, Guensch G, Mueller R. Study of fish response using particle image velocimetry and high-speed, high-resolution imaging. Prepared for the US Department of Energy. 2004.
3. Deng Z, Guensch G, McKinstry C, Mueller R, Dauble D, Richmond M. Evaluation of fish-injury mechanisms during exposure to turbulent shear flow. Can J Fish Aquat Sci. 2005; 62(7): 1513-1522.
4. Elkharwily A, Gottlieb K. The pancreas in familial adenomatous polyposis. J Pancreas. 2008; 9(1): 9-18.